Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of AOAC International|February 18, 2021
Determination of Total Proteinogenic Amino Acids and Taurine by Pre-column Derivatization and UHPLC: Single Laboratory Validation, First Action Official MethodSM 2019.09George Joseph, Asha Varughese, Ann Daniel
Australian Health Review : a Publication of the Australian Hospital Association|September 15, 2004
Patient satisfaction: the Australian patient perspectiveAmanda Henderson, Gideon Caplan, Ann Daniel
World Journal of Experimental Medicine|June 23, 2025
miRNA dysregulation in Duchenne muscular dystrophy comorbiditiesSubhashree Sivakumar, Archana Rajavel, Venkataraman Viswanathan, et al.
Frontiers in Immunology|October 14, 2022
MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysisEvangeline Ann Daniel, Balakumaran Sathiyamani, Kannan Thiruvengadam, et al.
Frontiers in Microbiology|April 6, 2023
Structural analysis and molecular dynamics simulation studies of HIV-1 antisense protein predict its potential role in HIV replication and pathogenesisBalakumaran Sathiyamani, Evangeline Ann Daniel, Samdani Ansar, et al.
Frontiers in Medicine|November 21, 2022
Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral controlJaisheela Vimali, Yean Kong Yong, Amudhan Murugesan, et al.
Diagnostic Microbiology and Infectious Disease|June 27, 2021
Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive reviewEvangeline Ann Daniel, Bennett Henzeler Esakialraj L, Anbalagan S, et al.
Tuberculosis (Edinburgh, Scotland)|December 18, 2025
Plasma biomarkers CRP, iFABP, and zonulin as predictors of tuberculosis progression in household contacts of pulmonary TB patientsAnuradha Rajamanickam, Evangeline Ann Daniel, Nikhil Gupte, et al.
Emerging Microbes & Infections|December 4, 2024
Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patientsEvangeline Ann Daniel, Shubham Upadhyay, Murugesan Selvachithiram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2022
QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis PatientsEvangeline Ann Daniel, Kannan Thiruvengadam, Anuradha Rajamanickam, et al.
Pageof 2